unknown
Stage
2
Investors
About
Cantoni Therapeutics is a preclinical stage biotech company developing novel small molecule therapeutics for inflammatory and autoimmune diseases, with a lead program targeting inflammatory bowel disease (IBD).
Explore Cantoni Therapeutics B.V's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.